Delivery Order SPE2DX25D9822-SPE2D226F0653
- Not listed
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order valued at $1,417.25 to DMS Pharmaceutical Group Inc. for Diazepam Injection on April 28, 2025. This firm fixed-price delivery order is set to be completed by May 8, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected without a set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $3,772.80 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on September 17, 2025, for the delivery of Diazepam Injection. The award, which carries an ultimate completion date of September 18, 2025, was issued without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The U.S. Defense Logistics Agency, operating through its Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for diazepam injection on September 17, 2025, with a ceiling value of $3,772.80. This firm fixed-price delivery order represents a single purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million through November 2026. The SPE2DB indefinite delivery vehicle enables the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,082.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Diazepam 10mg/2ml in quantities of 10 units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and represents a non-set-aside procurement. DMS Pharmaceutical Group will perform work at its facility in Park...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,854.60 on June 11, 2025, for the supply of Diazepam Injection. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of June 23, 2025, and utilizes no set-aside designation. The work will be performed in Park Ridge, Illinois, with funding provided by the Defense Department's Medical Supply Chain...
- The Defense Logistics Agency awarded a delivery order valued at $2,225.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Diazepam 5mg/ml in 2ml vials (10-count). The contract, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award was issued under DMS Pharmaceutical Group's existing...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of DIAZEPAM INJECTION. The $4,743.80 contract has a completion date of February 22, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that holds a larger indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, for a broad range of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,854.60 on August 20, 2025, for the supply of Diazepam Injection to the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, represents a continuation of pharmaceutical services under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The U.S. Department of Defense (DoD) awarded a $2,636.74 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Diazepam Injection and has an ultimate completion date of May 16, 2024. This contract is part of a larger $499,999,999 indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group by the Defense Logistics Agency (DLA) under the Medical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,298.22 by the Defense Logistics Agency's Medical Supply Chain on April 29, 2025, with a completion date of May 9, 2025. This firm fixed-price delivery order covers the supply of Diazepam Injection, a controlled pharmaceutical product used in military and federal healthcare facilities. The award carries no set-aside designation, and...
- SPE2DX25D9822Indefinite Delivery Contract
- SPE2DX25D9822-SPE2D226F0653Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of diazepam injection. This firm fixed-price delivery order, issued on December 30, 2025, has a ceiling value of $1,854.80 with an ultimate completion date of December 30, 2025. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical pharmaceutical supplier for Department of Defense healthcare operations. The contract authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/29/25 |